Anteris Technologies Global Corp (AVR)

Feb 28, 2025

Anteris to Present at Healthcare Investor ConferencesTD Cowen and Barclays - TradingView

Feb 28, 2025

Feb 18, 2025

Anteris Technologies Global (NASDAQ:AVR) Trading 1.9% Higher – What’s Next? - Defense World

Feb 18, 2025

Feb 18, 2025

Anteris Technologies Global (NASDAQ:AVR) Trading 1.9% HigherWhat's Next? - MarketBeat

Feb 18, 2025

Feb 13, 2025

Anteris Technologies Secures Favorable ATO Tax Rulings - TipRanks

Feb 13, 2025

Feb 11, 2025

Anteris Technologies Announces ASX Quotation of Securities - TipRanks

Feb 11, 2025

Feb 03, 2025

Anteris Technologies Adjusts CDI and Common Stock Holdings - TipRanks

Feb 03, 2025

Feb 03, 2025

Market report: ASX falls 1.79% as market declines across all sectors - Proactive Investors USA

Feb 03, 2025

Jan 30, 2025

Head-To-Head Analysis: Anteris Technologies Global (NASDAQ:AVR) vs. Inogen (NASDAQ:INGN) - Defense World

Jan 30, 2025

Jan 24, 2025

Cantor Fitzgerald Estimates AVR FY2025 Earnings - Defense World

Jan 24, 2025

Jan 23, 2025

L1 Capital Pty Ltd Acquires Significant Stake in Anteris Technol - GuruFocus.com

Jan 23, 2025

Jan 23, 2025

FY2025 Earnings Forecast for AVR Issued By Cantor Fitzgerald - MarketBeat

Jan 23, 2025

Jan 16, 2025

Anteris Technologies Expands Public Offering with Additional Share Issuance - TipRanks

Jan 16, 2025

Jan 15, 2025

Anteris Technologies announces partial IPO over-allotment exercise - Investing.com

Jan 15, 2025

Jan 15, 2025

Anteris Technologies announces partial IPO over-allotment exercise By Investing.com - Investing.com Canada

Jan 15, 2025

Jan 15, 2025

Healthcare outlook 2025: healthcare and biotech to regain investor focus - Proactive financial news

Jan 15, 2025

Jan 15, 2025

Anteris Technologies Global Corp’s Quiet Period Set To End on January 22nd (NASDAQ:AVR) - Defense World

Jan 15, 2025

Jan 14, 2025

Anteris Technologies Announces Partial Over-Allotment Exercise and End of IPO Stabilisation - TipRanks

Jan 14, 2025

Jan 13, 2025

FY2024 Earnings Forecast for AVR Issued By Cantor Fitzgerald - MarketBeat

Jan 13, 2025

Jan 10, 2025

Anteris Technologies Global Corp. Rings the Opening Bell - Nasdaq

Jan 10, 2025

Jan 10, 2025

Anteris Technologies Global (NASDAQ:AVR) Coverage Initiated at Lake Street Capital - Defense World

Jan 10, 2025

Jan 09, 2025

TD Cowen Begins Coverage on Anteris Technologies Global (NASDAQ:AVR) - Defense World

Jan 09, 2025

Jan 09, 2025

Barclays Initiates Coverage on Anteris Technologies Global (NASDAQ:AVR) - Defense World

Jan 09, 2025

Jan 09, 2025

Cantor Fitzgerald Initiates Coverage on Anteris Technologies Global (NASDAQ:AVR) - Defense World

Jan 09, 2025

Jan 07, 2025

Anteris Technologies Adjusts Stock Positions Between ASX and Nasdaq - TipRanks

Jan 07, 2025

Jan 07, 2025

Healthcare sector: back in focus in 2025 - Proactive Investors USA

Jan 07, 2025

Jan 07, 2025

Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst - Benzinga

Jan 07, 2025

Jan 07, 2025

Anteris Technologies Global (NASDAQ:AVR) Now Covered by Analysts at TD Cowen - MarketBeat

Jan 07, 2025

Jan 07, 2025

This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Jan 07, 2025

Jan 07, 2025

Anteris Technologies Global (NASDAQ:AVR) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat

Jan 07, 2025

Jan 07, 2025

Cantor Fitzgerald starts Anteris stock with Overweight rating - Investing.com

Jan 07, 2025

Dec 24, 2024

Admedus Limited Announces Approval for First-In-Human Surgical Aortic Valve Replacement Trial of Proprietary ADAPT Single-Piece 3D Aortic Valve At the Leuven University Hospitals - Marketscreener.com

Dec 24, 2024

Dec 21, 2024

Anteris Technologies’ Bold Shift to U.S. Markets - MSN

Dec 21, 2024

Dec 20, 2024

Admedus Limited to Relocate Corporate Services Functions to Brisbane; Announces Executive Changes - Marketscreener.com

Dec 20, 2024

Dec 20, 2024

Heart valve developer Anteris launches IPO - MedTech Dive

Dec 20, 2024

Dec 20, 2024

Admedus Ltd : Admedus's CardioCel® Cleared for Sale in the US - Marketscreener.com

Dec 20, 2024

Dec 19, 2024

Anteris Technologies Redeems Convertible Notes - TipRanks

Dec 19, 2024

Dec 19, 2024

Anteris Technologies Announces New Director Appointment - TipRanks

Dec 19, 2024

Dec 19, 2024

Anteris Technologies Debuts on NASDAQ with IPO - MSN

Dec 19, 2024

Dec 19, 2024

Anteris Technologies Prepares for Stock Market Expansion - MSN

Dec 19, 2024

Dec 19, 2024

Anteris Completes Key Animal Study for EFS Submission - Marketscreener.com

Dec 19, 2024

Dec 19, 2024

Allied Healthcare Group Ltd : Allied reports no calcification from phase II CardioCel patients after 5 years - Marketscreener.com

Dec 19, 2024

Dec 19, 2024

Anteris Technologies Ltd Provides Data Update on First in Human Study of DurAVR THV Presented At New York Valves 2024 - Marketscreener.com

Dec 19, 2024

Dec 19, 2024

Anteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Boston - Marketscreener.com

Dec 19, 2024

Dec 19, 2024

Admedus Limited Appoints Maja Mcguire as Company Secretary - Marketscreener.com

Dec 19, 2024

Dec 19, 2024

Anteris Submits Confidential Draft Registration Statement for Proposed US IPO - Marketscreener.com

Dec 19, 2024

Dec 18, 2024

Anteris Technologies Ltd Reports Successful Interim Results for the First-In-Human Trial - Marketscreener.com

Dec 18, 2024

Dec 18, 2024

US FDA Allows Manufacturing to Start at Anteris Technologies' Expanded Production Facility for DurAVR THV - Marketscreener.com

Dec 18, 2024

Dec 18, 2024

Anteris Technologies Ltd Announces FDA Allows Manufacturing to Begin At Expanded Facility - Marketscreener.com

Dec 18, 2024

Dec 18, 2024

Admedus Limited Announces Management Changes - Marketscreener.com

Dec 18, 2024

Dec 18, 2024

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering - Marketscreener.com

Dec 18, 2024